Bausch Health Co. Inc. (BHC) Misses Q4 EPS by 201c

Bausch Health Co. Inc. (NYSE: BHC) reported Q4 EPS of ($1.13), $2.01 worse than the analyst estimate of $0.88. Revenue for the quarter came in at $2.19 billion versus the consensus estimate of $2.14 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c